Renal Denervation Insights

Published: 12 February 2021

Views:
28457
Likes:
7

Views:
28457
Likes:
7
Share:

Now Playing
Part 1 | Session 5 of 7
Clinical Event Reductions in High-Risk Hypertension Patients Treated with Radiofrequency Renal Denervation
Roland E Schmieder

Up Next
5m 3s

Part 1 | Session 6 Radiofrequency Renal Denervation in a High-risk Population: The Verona experience
Flavio Ribichini
6m 40s

Part 1 | Session 7 Patient Profiles for Renal Denervation
Isabella Sudano

30m 24s

Part 2 | Session 1 The Science of Radiofrequency Renal Denervation – Part 1
Andrew SP Sharp, Stefan Tunev
1h 12m 55s

Part 2 | Session 2 The Science of Radiofrequency Renal Denervation – Part 2
Andrew SP Sharp, Stefan Tunev
9m 14s

Part 2 | Session 3 TCT 2019: RF renal denervation – Prof Andrew Sharp
Andrew SP Sharp

59m 59s

Part 1 | Session 1 The Future of Hypertension Management – Renal Denervation Provides Another Treatment Option Justin E Davies, Faisal Sharif, Roland E Schmieder, Flavio Ribichini, Isabella Sudano

1h 1m 3s

Part 1 | Session 2 El futuro del manejo de la hipertensión: la denervación renal brinda otra opción de tratamiento Oriol Rodriguez, Maribel Troya

59m 14s

Part 1 | Session 3 Die Zukunft des Hypertoniemanagements – Renale Denervierung bietet eine weitere Behandlungsoption Joachim Weil, Oliver Dörr

1h 2m 27s

Part 1 | Session 4 Il futuro della gestione dell’ ipertensione - La Denervazione renale, una nuova opzione di trattamento Flavio Ribichini, Stefano Taddei

Average (ratings)

No ratings

Your rating

Overview

Global Experts Discuss Renal Denervation as an Additional Treatment Option for Uncontrolled Hypertension

Review the evidence on radiofrequency renal denervation, including safety, efficacy and durability data and practical aspects around patient selection and management.

Medical Education Program

Patient Selection and Practical Implementation of Renal Denervation in Patients With Treatment-Resistant Hypertension

This case-based course brings together opinion leaders engaged in RDN to review the evidence, discuss trial data, and practical aspects around patient selection and management.

Click here to watch:

IME series

CME education

This educational content is supported by Medtronic.

More from this programme

Part 1

Clinical Data and Patient Identification

Global leaders share their expertise in the field of Renal Denervation. Key topics include latest RDN clinical evidence including Pivotal trial results, how to identify potential RDN patients, and the role of patient preference in hypertension management. Presented in English, Spanish, Italian, and German.

7 sessions
The Future of Hypertension Management – Renal Denervation Provides Another Treatment Option	Watch now
El futuro del manejo de la hipertensión: la denervación renal brinda otra opción de tratamiento	Watch now
Die Zukunft des Hypertoniemanagements – Renale Denervierung bietet eine weitere Behandlungsoption	Watch now
Il futuro della gestione dell’ ipertensione - La Denervazione renale, una nuova opzione di trattamento	Watch now
Clinical Event Reductions in High-Risk Hypertension Patients Treated with Radiofrequency Renal Denervation	Watch now
Radiofrequency Renal Denervation in a High-risk Population: The Verona experience	Watch now
Patient Profiles for Renal Denervation	Watch now

Part 2

Science of Radiofrequency Renal Denervation

Experts explain the mechanism of action behind radiofrequency renal denervation, including evidence demonstrating long-term safety and efficacy.

3 sessions
The Science of Radiofrequency Renal Denervation – Part 1	Watch now
The Science of Radiofrequency Renal Denervation – Part 2	Watch now
TCT 2019: RF renal denervation – Prof Andrew Sharp	Watch now

Faculty Biographies

Roland E Schmieder

Professor of Internal Medicine, Nephrology and Hypertension, Head of the Clinical Research Centre and Vice Chair of the Department of Nephrology and Hypertension

Roland E Schmieder is a Professor of Internal Medicine, Nephrology and Hypertension, Head of the Clinical Research Centre and Vice Chair of the Department of Nephrology and Hypertension at the University Hospital Erlangen, Germany. He also directs the Institute of Preventative Medicine at the University Erlangen-Nuremberg and the Community Hospital Nuremberg. Roland is a member of numerous professional societies and committees, and is a Fellow of the American College of Physicians (ACP) and the American College of Cardiology (ACC). He is on the international Editorial Board of the American Journal of Hypertension, the Journal of Human Hypertension and the Journal of Nephrology, among other scientific journals. Professor Schmieder received his post-graduate medical training in nephrology, cardiology and hypertension at the University Hospital of Bonn, and then at the Alton Ochsner Foundation, New Orleans. He graduated in medicine from the…

View full profile